Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry

OBJECTIVE. This study aimed to investigate the efficacy, safety and survival of TNF-α inhibitors in patients with RA. METHODS. A total of 178 patients >18 years of age were treated with TNF-α inhibitors. A total of 74 patients were treated with infliximab, 75 with adalimumab and 29 with etanercep...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Rheumatol Adv Pract
Hlavní autoři: Papadopoulos, Christos G, Gartzonikas, Ilias K, Pappa, Tatiani K, Markatseli, Theodora E, Migkos, Michael P, Voulgari, Paraskevi V, Drosos, Alexandros A
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6649942/
https://ncbi.nlm.nih.gov/pubmed/31431995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkz007
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky